These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 29670110)

  • 1. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
    Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
    Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.
    Pramanik KC; Makena MR; Bhowmick K; Pandey MK
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
    Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.
    Kühnemuth B; Mühlberg L; Schipper M; Griesmann H; Neesse A; Milosevic N; Wissniowski T; Buchholz M; Gress TM; Michl P
    Oncogene; 2015 Jan; 34(2):177-87. PubMed ID: 24336331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C; Zhao Z; Zhou Z; Liu R
    Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
    Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
    Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
    Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
    Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.
    Shimazaki R; Takano S; Satoh M; Takada M; Miyahara Y; Sasaki K; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Sogawa K; Motohashi S; Nomura F; Miyazaki M; Ohtsuka M
    Cell Oncol (Dordr); 2021 Aug; 44(4):937-950. PubMed ID: 34075561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma.
    Ye H; Zhou Q; Zheng S; Li G; Lin Q; Ye L; Wang Y; Wei L; Zhao X; Li W; Fu Z; Liu Y; Li Z; Chen R
    Cell Death Dis; 2018 Jan; 9(2):34. PubMed ID: 29348628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
    Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
    J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.
    Ma Q; Wu X; Wu J; Liang Z; Liu T
    Int J Oncol; 2017 Oct; 51(4):1104-1114. PubMed ID: 28902358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.